News

Abacus Medicine Pharma Services is the new name for the healthcare and pharma services company previously known as Aposave. Simon Estcourt, Managing Director, Abacus Medicine Pharma Services explains the rebranding: “The new brand makes it very clear who we are and...

According to Moderna’s CEO, Stephane Bancel, the company is aiming to bring to the market a combination of COVID-19 and influenza booster in the coming two years. In an official announcement made by him, the single-shot vaccine against the...

As per GlobalData’s Thematic Research ecosystem, pharmaceutical giants Novartis and Pfizer are the best-positioned companies to take advantage of future biosimilars in the pharma landscape. This ecosystem by GlobalData positions companies on a one to five scale, predominantly on the...

Pfizer Inc. and BioNTech SE announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate in healthy adults 18 through 55 years of age. The study will have three cohorts...

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,  announced that Australia's Therapeutic Goods Administration (TGA) has granted approval for provisional registration of NVX-CoV2373, Novavax' COVID-19 vaccine (adjuvanted), for active immunization to...

Bristol-Myers Squibb announced that Japan’s Ministry of Health, Labour and Welfare has approved Abecma (idecabtagene vicleucel), a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy, for the treatment of adult patients with relapsed or refractory (R/R)...

Evotec SE announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company in the field of metabolic diseases with a focus on kidney diseases and diabetes. The collaboration leverages Evotec’s extensive experience and...